Andrew Ransom

Responsible for Market Access, Government Relations and Health Policy strategies for BC and Manitoba. Identify health policy barriers and ensure optimal policy conditions and reimbursement for current and future Boehringer Ingelheim products.

Successful PLA/Listings to date:

• Jardiance T2D 3rd line Manitoba (2017)
• Jardiance for 2nd line Manitoba (2019)
• Jardiance T2D in BC (only exclusive SGLT2 listing in Canada – 2020)
• Ofev for IPF in Manitoba (2017)
• Ofev for IPF in BC (2018)
• Ofev for PF-ILD in Manitoba (2022)
• Ofev for PF-ILD in BC (2022)
• Inspolito and Spiriva as part of successful class reviews in both BC and Manitoba (2021)

Policy/GR:

• Innovative Medicines Canada (IMC) Western Operation Team member (Western Canada): 2021- present
• Drugs for Rare Disease strategy and GR working groups (national)
• HeartLife Foundation policy lead (national)
• PATHWAYS Indigenous Health Policy Team (national)

As Healthcare Affairs Manager for BC and Manitoba I was responsible for:

• Creating innovative and sustainable quality improvement partnerships and partnerships with various stakeholders at multiple levels within the healthcare system, to improve healthcare deliver and improve patient outcomes.
• Developing strong business relationships with the BC and Manitoba Health Authorities, including government agencies for reimbursement, regional health authorities, hospital administrators, clinical and academic institutions and physicians
• Understanding the complex nature of the provincial healthcare systems and the various economic and political stakeholders that work within it. Linking provincial, regional, local health policies and programs to access, policy and clinical practice opportunities in Boehringer's therapeutic areas of interest

Responsible for the sales and marketing implementation of Pradaxa (Dabigatran) into the BC health system, primarily at the specialist and hospital level. This included:

• Hospital formulary listing and utilization protocols
• Working with cross functional teams and mentoring representatives across BC
• Key customer groups: cardiologists, stroke neurologists, hematologists, internal medicine specialists and hospital pharmacists and administrators.

Projects/Achievements/Leadership:

• 2nd highest sales in Canada 2014
• Secured drug formulary listing throughout Fraser Health Authority and Interior Health Authority Hospitals
• Highest market share nationally for a hospital/specialist territory (2012/13)

Responsibilities:

• Manage the sales and key accounts of half of BC (Fraser Health, Interior Health, BCCA sites) for Merck Canada, looking after Oncology products (Temodal, Intron A, and Emend). This included market access: cancer protocol inclusion for the BC Cancer Agency, as well as Hospital Formulary inclusion of inpatient products through BCHA.
• Manage the following specialist groups: Medical Oncologists, Neurosurgeons, Radiation Oncologists, Dermatologists, General Surgeons, Oncology Nurses and Pharmacists.

Projects/Achievements/Leadership:

• Achieved 120% sales targets, in addition to 50% growth in my product portfolio over 12 months

• Key Customer groups – Orthopedic Surgeons, Hematologists, OR and Orthopedic nurses, Anesthetists, Vascular Surgeons/Physicians, Directors of Pharmacy, Hospital Administrators
• Projects/Achievements/Leadership:
• Market access, including successful Hospital Formulary listings (18 in total), as well as commercial negotiations for Xarelto into private hospitals in NSW
• Marketing Projects: Developed two new marketing brand materials for 2010 as part of a marketing development plan. These were rolled out nationally and form part of the 2010 strategy (2009 and 2010)
• Training and Recruitment of new specialist representatives as the department grew.

• Managing the sales to Specialists and Hospitals in NSW in the Anti-Infective and Pulmonary Hypertension (PAH) markets.
• Ensuring Hospital Formulary listing for Bayer products in all major public hospitals health authorities in NSW, Australia

• Managing the sales of various prescription medications and ensuring that sales targets are met

• My role was to write and implement exercise-training programs for patient rehabilitation. This role worked closely with physiotherapists to provide optimal rehabilitation for patients with sports injuries and chronic physical problems.